Brief: BioArctic Q3 Operating Profit SEK -28.8 Million
13/11/2025 07:00
Nov 13 (Reuters) - BioArctic Q3 adjusted EPS SEK -0.98. Q3 net income SEK -86.9 million Q3 revenue SEK 133.3 million Q3 adjusted free cash flow SEK -41.2 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln